About the Authors
- Rhea N. Coler
-
Contributed equally to this work with: Rhea N. Coler, Sylvie Bertholet
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Sylvie Bertholet
-
Contributed equally to this work with: Rhea N. Coler, Sylvie Bertholet
Current address: Vaccines and Diagnostics, Novartis, Siena, Italy
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Magdalini Moutaftsi
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Jeff A. Guderian
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Hillarie Plessner Windish
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Susan L. Baldwin
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Elsa M. Laughlin
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Malcolm S. Duthie
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Christopher B. Fox
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Darrick Carter
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Martin Friede
-
Affiliation Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland
- Thomas S. Vedvick
-
Affiliation Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America
- Steven G. Reed
-
* E-mail: sreed@idri.org
Affiliations Preclinical Biology, Infectious Disease Research Institute, Seattle, Washington, United States of America, Immune Design Corp., Seattle, Washington, United States of America
Competing Interests
Dr. Reed is a founder of, and holds an equity interest in, Immune Design Corp., a licensee of certain rights associated with GLA. This does not alter the authors' adherance to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RNC SB MM SLB HPW. Performed the experiments: MSD MM JAG HPW SB EML CBF TSV. Analyzed the data: RNC MM SB. Wrote the paper: RNC MM SB. Edited the manuscript: SGR DC MF.